Zaika Oleg, Tomilin Viktor, Mamenko Mykola, Bhalla Vivek, Pochynyuk Oleh
Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center at Houston, Houston, Texas; and
Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center at Houston, Houston, Texas; and.
Am J Physiol Renal Physiol. 2016 May 15;310(10):F923-30. doi: 10.1152/ajprenal.00577.2015. Epub 2016 Jan 20.
Since its identification as the underlying molecular cause of Bartter's syndrome type 3, ClC-Kb (ClC-K2 in rodents, henceforth it will be referred as ClC-Kb/2) is proposed to play an important role in systemic electrolyte balance and blood pressure regulation by controlling basolateral Cl(-) exit in the distal renal tubular segments from the cortical thick ascending limb to the outer medullary collecting duct. Considerable experimental and clinical effort has been devoted to the identification and characterization of disease-causing mutations as well as control of the channel by its cofactor, barttin. However, we have only begun to unravel the role of ClC-Kb/2 in different tubular segments and to reveal the regulators of its expression and function, e.g., insulin and IGF-1. In this review we discuss recent experimental evidence in this regard and highlight unexplored questions critical to understanding ClC-Kb/2 physiology in the kidney.
自被确定为3型巴特综合征的潜在分子病因以来,ClC-Kb(在啮齿动物中为ClC-K2,以下将其称为ClC-Kb/2)被认为通过控制从皮质厚升支到外髓集合管的远端肾小管节段基底外侧Cl⁻的流出,在全身电解质平衡和血压调节中发挥重要作用。大量的实验和临床研究致力于鉴定和表征致病突变以及通过其辅助因子barttin对该通道的调控。然而,我们才刚刚开始揭示ClC-Kb/2在不同肾小管节段中的作用,并揭示其表达和功能的调节因子,例如胰岛素和IGF-1。在这篇综述中,我们讨论了这方面的最新实验证据,并强调了对于理解肾脏中ClC-Kb/2生理学至关重要但尚未探索的问题。